Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

Special Report

NeurologyLive Peer Exchange

Medcast

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Videos

The professor of neurology at the University of Texas Health Science Center San Antonio discussed some of the challenges with therapeutic development for OPMD, as well as advances and barriers to gene therapy approaches. [WATCH TIME: 4 minutes]

Translating Oculopharyngeal Muscular Dystrophy Research Into Clinical Application: Matthew Wicklund, MD

The clinical associate professor of neurology and neurosurgery at NYU Langone Health emphasized the importance of rapid, targeted blood pressure reduction and bundled care to improve outcomes in patients with intracerebral hemorrhage. [WATCH TIME: 4 minutes]

The Key Role of Early and Balanced Blood Pressure Control in ICH Management: Kara R. Melmed, MD

Articles

Relative to previously approved therapies like rimegepant, ubrogepant, and zavegepant, AXS-07 resulted in better 2-hour pain relief, sustained pain relief, and reduced use of rescue medications.

AXS-07 Outperforms Other CGRP-Targeting Gepants in Meta-Analysis

The Melissa and Paul Anderson President’s Distinguished Professor of Neurology, Perelman School of Medicine, University of Pennsylvania discussed evolving insights into the cellular immunology of multiple sclerosis. [WATCH TIME: 4 minutes]

Understanding the Cellular Drivers of MS Progression and Treatment Response: Amit Bar-Or, MD, FRCPC, FAAN, FANA

Clinical associate professor of neurology and neurosurgery at NYU Langone Health. 

Senior vice president of research at The ALS Association. 

The senior vice president of research at The ALS Association talked about a multidisciplinary session presented at the 2025 MDA Conference that highlighted diverse strategies for neural repair, from pharmacological targets to noninvasive brain stimulation. [WATCH TIME: 6 minutes]

Exploring Multimodal Approaches to Neural Regeneration: Kuldip Dave, PhD

Marco Meglio, Assistant Managing Editor for 

, has been with the team since October 2019. Follow him on Twitter 

In this final episode, neurologists discuss the role of advanced imaging, like OCT, in diagnosing and managing MS, emphasizing the need for further research to optimize its clinical application. [WATCH TIME: 2 minutes]

Bridging Neurology and Ophthalmology in Multiple Sclerosis Research

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AAN 2025

AD/PD 2025

MDA 2025

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

News Network

1rem

View

Sleep Disorders and Health Conditions: Focus on Insomnia

An expert cardiologist, sleep specialist, and pulmonologist, share insights on the awareness and treatment of sleep disorders, including insomnia, that co-occur with other health conditions.

Dr Nathaniel F. Watson, MD, provides insight on the prevalence of various sleep disorders, including insomnia, and patient populations at high-risk for developing these disorders.

Overview of Sleep Disorders

Ashgan A. Elshinawy, DO, leads a discussion on the co-occurrence and relationship between sleep disorders and different health conditions in patients.

Co-occurrence of Sleep Disorders With Other Health Conditions

Nathaniel F. Watson, MD; Ashgan A. Elshinawy, DO; and C. Michael Gibson, MD, examine complications patients encounter with sleep disorders, including for insomnia, and the impact on their quality of life.

Complications of Sleep Disorders and Impact on Quality of Life

Dr Nathaniel F. Watson reviews screening patients for sleep disorders and referral to sleep specialists.

Screening for Sleep Disorders

Experts in sleep medicine stress the importance of early diagnosis of sleep disorders and how they approach treatment in their clinics.

Approaching Diagnosis and Treatment of Sleep Disorders and Co-occurring Health Conditions

Ashgan A. Elshinawy, DO, comments on engaging patients in conversations around managing sleep disorders with co-occurring health conditions.

Role of Patient Communication in Sleep Disorder Management

Dr Ashgan A. Elshinawy and C. Michael Gibson considers safety and efficacy factors when approaching treatment selection for sleep disorders and insomnia.

Treatment Selection for Sleep Disorders

Nathaniel F. Watson, MD, reviews the pathways involved in sleep and wakefulness cycles as it relates to sleep disorders.

Sleep Disorders: Sleep and Wakefulness Pathways

Drs Ashgan A. Elshinawy, C. Michael Gibson, and Nathaniel F. Watson discuss FDA-approved medications currently used for the treatment of sleep disorders and insomnia, and comment on the difference between DORAs.

FDA-Approved Therapies for the Management of Sleep Disorders

Nathaniel F. Watson, MD, highlights the use of daridorexant for treating patients with insomnia as seen from phase 3 trials and data presented at the World Sleep 2022 meeting and managing adverse events.

Phase 3 Studies With Daridorexant for Insomnia Management

Ashgan A. Elshinawy, DO, shares her approach to treatment selection of DORAs and switching therapies for the management of sleep disorders.

Selecting Specific DORAs for Insomnia

Drs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson examine setting treatment expectations with patients and treatment adherence for sleep disorders.

Treatment Adherence in Sleep Disorders

Experts in sleep medicine share emerging treatments in the pipeline for the management of sleep disorders.

Emerging Treatment Options for Sleep Disorders

Nathaniel F. Watson, MD, leads a discussion on gaps in care and unmet needs for patients and healthcare professionals in the area of sleep disorders.

Unmet Needs in Sleep Disorder Management

Drs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson share resources for the treatment of sleep disorders.

Resources for Sleep Disorders

Peer Exchange

Clinical

 Peer Exchange video series features panels of expert physicians engaging in in-depth discussions about practice-changing treatments, challenges in care, and the future paradigm of management for neurologic diseases.

Role of Patient Communication in Sleep Disorder Management

EP: 1.Overview of Sleep Disorders

EP: 2.Co-occurrence of Sleep Disorders With Other Health Conditions

EP: 3.Complications of Sleep Disorders and Impact on Quality of Life

EP: 4.Screening for Sleep Disorders

EP: 5.Approaching Diagnosis and Treatment of Sleep Disorders and Co-occurring Health Conditions

EP: 6.Role of Patient Communication in Sleep Disorder Management

EP: 7.Treatment Selection for Sleep Disorders

EP: 8.Sleep Disorders: Sleep and Wakefulness Pathways

EP: 9.FDA-Approved Therapies for the Management of Sleep Disorders

EP: 10.Phase 3 Studies With Daridorexant for Insomnia Management

EP: 11.Selecting Specific DORAs for Insomnia

EP: 12.Treatment Adherence in Sleep Disorders

EP: 13.Emerging Treatment Options for Sleep Disorders

EP: 14.Unmet Needs in Sleep Disorder Management

EP: 15.Resources for Sleep Disorders